Market Cap 6.64M
Revenue (ttm) 0.00
Net Income (ttm) -17.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.02
Volume 20,300
Avg Vol 17,413
Day's Range N/A - N/A
Shares Out 1.15M
Stochastic %K 93%
Beta 0.53
Analysts Sell
Price Target $27.00

Company Profile

Akari Therapeutics, Plc, an oncology company, develops next-generation antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company's lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2 antibody to treat solid tumor cancer types, including lung, breast, colon, and prostate. Its payloads in...

Industry: Biotechnology
Sector: Healthcare
Phone: 929 274 7510
Fax: 929 274 7553
Address:
22 Boston Wharf Road, Floor 7, Boston, United States
MTN
MTN Apr. 17 at 6:45 PM
$AKTX for those new here, this is not where you invest. They have a good patent portfolio and have done nothing with it. Short term and long term, you will lose your investment here. Average long term holders price average is $200+ (RS after RS).
0 · Reply
cfvk
cfvk Apr. 17 at 5:32 PM
$AKTX still holding some 3.4s, like 60%
0 · Reply
ArrogantInvestor
ArrogantInvestor Apr. 11 at 6:41 PM
$AKTX One day was all it took to register an additional 867 000 shares.
0 · Reply
VirtualInvestor
VirtualInvestor Apr. 9 at 4:50 PM
$AKTX Akari Participates in Virtual Investor “What This Means” Interview Discussing Strategic Partnership with WuXi XDC https://vimeo.com/1181533226/888a673892?fl=ip&fe=ec
0 · Reply
TATTED_KEN
TATTED_KEN Apr. 7 at 6:06 PM
$AKTX hitting scanners.
0 · Reply
focafoca99
focafoca99 Apr. 6 at 6:38 PM
$AKTX partnered with WuXi XDC to move its ADC payload program forward, with a Phase 1 start targeted for late 2026 or early 2027.
0 · Reply
ArrogantInvestor
ArrogantInvestor Apr. 6 at 3:11 PM
$AKTX How long till the 8-K ? Place your bets.
0 · Reply
Zonata
Zonata Apr. 6 at 2:52 PM
$AKTX I'm not good at cutting my losses, but at least I'm usually good at knowing when to NOT average down. This one is in the list, and from my initial investment I have 14$ left. I'm happy I chose to resist the temptation to buy more on the way down, because my losses would be huge.
0 · Reply
FshOn
FshOn Apr. 6 at 2:18 PM
$AKTX I’m sure to take this off my watch list. Man o man
0 · Reply
StockElementCorporation
StockElementCorporation Apr. 6 at 1:21 PM
Premarket movers 📈 Upside: $PFSA +118% — PanOmics deal expansion $SLNO +33% — $2.9B buyout by Neurocrine $NVNI +32% — acquisition stake deal $AKTX +25% — ADC partnership $AAOI +6.6% — 800G order PLTK +4.7% — strategic review BOOT +4.1% — analyst upgrade KTOS +3.7% — analyst upgrade MU +3.6% — reiteration TWLO +3.6% — analyst upgrade HOLO +3.5% — crypto upgrade investment COIN +3.3% — OCC approval momentum AMKR +3.1% — analyst upgrade JBS +2.5% — strike resolution NFLX +1.8% — analyst upgrade Downside: VELO -13% — shelf offering
0 · Reply
Latest News on AKTX
Akari Therapeutics Announces ADS Ratio Change

Mar 17, 2026, 4:30 PM EDT - 4 weeks ago

Akari Therapeutics Announces ADS Ratio Change


Akari Therapeutics to Present at the 2026 Biotech Showcase

Jan 8, 2026, 9:15 AM EST - 3 months ago

Akari Therapeutics to Present at the 2026 Biotech Showcase


Akari Therapeutics Announces Launch of CEO Corner Platform

Oct 22, 2025, 9:05 AM EDT - 6 months ago

Akari Therapeutics Announces Launch of CEO Corner Platform


Akari Therapeutics Announces Key Leadership Appointments

Dec 18, 2024, 8:51 AM EST - 1 year ago

Akari Therapeutics Announces Key Leadership Appointments


MTN
MTN Apr. 17 at 6:45 PM
$AKTX for those new here, this is not where you invest. They have a good patent portfolio and have done nothing with it. Short term and long term, you will lose your investment here. Average long term holders price average is $200+ (RS after RS).
0 · Reply
cfvk
cfvk Apr. 17 at 5:32 PM
$AKTX still holding some 3.4s, like 60%
0 · Reply
ArrogantInvestor
ArrogantInvestor Apr. 11 at 6:41 PM
$AKTX One day was all it took to register an additional 867 000 shares.
0 · Reply
VirtualInvestor
VirtualInvestor Apr. 9 at 4:50 PM
$AKTX Akari Participates in Virtual Investor “What This Means” Interview Discussing Strategic Partnership with WuXi XDC https://vimeo.com/1181533226/888a673892?fl=ip&fe=ec
0 · Reply
TATTED_KEN
TATTED_KEN Apr. 7 at 6:06 PM
$AKTX hitting scanners.
0 · Reply
focafoca99
focafoca99 Apr. 6 at 6:38 PM
$AKTX partnered with WuXi XDC to move its ADC payload program forward, with a Phase 1 start targeted for late 2026 or early 2027.
0 · Reply
ArrogantInvestor
ArrogantInvestor Apr. 6 at 3:11 PM
$AKTX How long till the 8-K ? Place your bets.
0 · Reply
Zonata
Zonata Apr. 6 at 2:52 PM
$AKTX I'm not good at cutting my losses, but at least I'm usually good at knowing when to NOT average down. This one is in the list, and from my initial investment I have 14$ left. I'm happy I chose to resist the temptation to buy more on the way down, because my losses would be huge.
0 · Reply
FshOn
FshOn Apr. 6 at 2:18 PM
$AKTX I’m sure to take this off my watch list. Man o man
0 · Reply
StockElementCorporation
StockElementCorporation Apr. 6 at 1:21 PM
Premarket movers 📈 Upside: $PFSA +118% — PanOmics deal expansion $SLNO +33% — $2.9B buyout by Neurocrine $NVNI +32% — acquisition stake deal $AKTX +25% — ADC partnership $AAOI +6.6% — 800G order PLTK +4.7% — strategic review BOOT +4.1% — analyst upgrade KTOS +3.7% — analyst upgrade MU +3.6% — reiteration TWLO +3.6% — analyst upgrade HOLO +3.5% — crypto upgrade investment COIN +3.3% — OCC approval momentum AMKR +3.1% — analyst upgrade JBS +2.5% — strike resolution NFLX +1.8% — analyst upgrade Downside: VELO -13% — shelf offering
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 6 at 12:46 PM
$AKTX (+14.1% pre) Akari Therapeutics partners with WuXi XDC for ADC payload development https://ooc.bz/l/98020
0 · Reply
Stock_Catcher
Stock_Catcher Apr. 6 at 12:45 PM
$AKTX Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing
0 · Reply
RetireB4FortyX
RetireB4FortyX Apr. 5 at 6:56 PM
$AIIO $PSTV $MODD $SVRN $AKTX Reverse Split Stocks For This Week's Watchlist Reverse Split Analysis Here: https://retireb4forty.com/reverse-split-stocks/f/reverse-split-stocks-to-watch-for-this-week-of-april-6-2026 Will look to have Full Stock Analysis on each this week. Make sure to follow along and sign up for our free newsletter
0 · Reply
PaulLaurent
PaulLaurent Apr. 3 at 7:35 PM
📉🔥 Highest Short Interest Stocks 🔥📉 Based on the highest reported short interest figures — recent reverse splits may not be fully reflected yet. $XHG $AKTX $PAVS $DXST $CDNL
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 3 at 4:15 AM
$AKTX RSI: 17.57, MACD: -1.3544 Vol: 2.27, MA20: 7.06, MA50: 8.70 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
mds22
mds22 Apr. 2 at 5:48 PM
$AKTX Management is aware that just a reverse split will not do anything - they need to provide results - correct??
0 · Reply
TwongStocks
TwongStocks Mar. 31 at 8:13 PM
$AKTX 1 for 40 Previous close $0.1210, $4.84 split-adjusted Intraday high $5.45 Today's close $5.15 🟢Up 6.40% $MODD 1 for 30 Previous close $0.1516, $4.548 split-adjusted Intraday high $6.16 Today's close $5.28 🟢Up 16.09% $PAVS 1 for 12 Previous close $0.1658, $1.9896 split-adjusted Premarket high $2.91 Today's close $2.13 🟢Up 7.06%
0 · Reply
coachmc
coachmc Mar. 31 at 3:29 PM
$AKTX turd sandwich. Does prudo even care?
0 · Reply
TwongStocks
TwongStocks Mar. 31 at 11:23 AM
$AKTX $MODD $PAVS All three with reverse splits today. Trading is scheduled to resume at 9:00am ET, with the RS in effect. RS details are in the quoted post.
0 · Reply
CaliberPalaceTrades
CaliberPalaceTrades Mar. 31 at 4:27 AM
$AKTX halted overnight?
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Mar. 31 at 2:39 AM
🌅 Watchlist part 2 ✅ $PAVS 1/12 reverse split, new price ~1.93 ✅ $MODD 1/30 RS, new price ~4.50 ✅ $AKTX 1/40 RS, new price ~4.80 🚨 The above tickers are not ideal for swing accumulation at current price 🚨 ✅ Ideal long entry near key support 🎯 Ideal stop loss if below support 🚨 Avoid chasing strength near resistance ⏳⏳ $PEPG $TMDE still in swing accumulation phase 🎯🎯 Goal is GREEN, not GREED
0 · Reply
Brentney
Brentney Mar. 31 at 1:47 AM
$AKTX rocket ship prepared for liftoff! Lmao can we can @Nick1971 and others in her to sunshine pump for ole time sake. AKTK, I wish I had never heard those 4 letters put together. May you forever go fuck yourself and every executive associated with its name be forever tarnished for the 🗑️ you delivered! 🤡’s
1 · Reply